SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)The suspension of trading in the securities of Imricor Medical Systems Inc will be lifted immediately following the release by IMR of an announcement regarding a capital raise. | 20/03/2025 |
The company releases its Equity Raising Presentation. | 20/03/2025 |
The company has completed a successful capital raise of A$70 million, raising $44.1 million through a strongly-supported placement to sophisticated investors. The proceeds will be used to accelerate Imricor's growth strategy, including expanding commercial operations and supporting regulatory efforts. | 20/03/2025 |
The securities of Imricor Medical Systems, Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of IMR, pending the release of an announcement regarding a proposed capital raising. | 19/03/2025 |
The suspension of trading in the securities of Imricor Medical Systems, Inc. will be lifted immediately following the release by IMR of an announcement regarding a proposed capital raising. | 05/02/2024 |
The Company has received firm commitments for its institutional placement placement to US investors and the institutional component of its 1 for 7.5 pro-rata accelerated non-renounceable entitlement offer of new CHESS Depositary Interests. The Institutional Placement, US Placement and Institutional Entitlement Offer will raise approximately A$8.0 million in total at an issue price of A$0.45 per CDI and share. The offer was well supported by existing shareholders as well as attracting new institutional shareholders to the register. | 05/02/2024 |
The company releases a Capital Raising Presentation. | 02/02/2024 |
The company releases a cleansing notice for the capital raising earlier announced. | 02/02/2024 |
The company releases a notice of proposed issue of securities. | 02/02/2024 |
The Company is undertaking an institutional placement, a placement to US investors and an entitlement offer to raise up to ~A$15.0 million. | 02/02/2024 |
The securities of Imricor Medical Systems, Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of IMR, pending the release of an announcement regarding a proposed capital raising. | 02/02/2024 |
The suspension of trading in the securities of Imricor Medical Systems, Inc. will be lifted immediately following the release by IMR of an announcement regarding a proposed capital raising. | 24/10/2023 |
The Company has completed a placement to raise A$4.28 million. Investors outside the US purchased a total of 7,126,000 CDIs at A$0.50 per CDI. These investors also received 10-year warrants to purchase a total of 1,781,500 additional CDIs at A$0.95 per CDI. The Company has drawn A$145,822 as a second tranche from the A$30 million Security Subscription Facility with GEM Global Yield SCS. The draw was a partial draw, cancelled before completion due to the Placement. The Company is issuing 309,600 CDIs to GGY at an issue price of approximately A$0.471 per CDI. The funds received are expected to be applied in a similar manner to those raised under the Placement. The issue price represents 90% of the average closing bid price of the Company's CDIs over the 15 consecutive trading days that followed the submission of the draw down notice to GGY, as adjusted in accordance with the terms of the SSF. | 24/10/2023 |
The securities of Imricor Medical Systems, Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of IMR, pending the release of an announcement regarding a proposed capital raising. | 23/10/2023 |
listed entity carried for record purposes only | 30/08/2019 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 05/06/2025 | Mark Tibbles | 170,000 | $1.680 | $285,600.00 |
| 07/05/2024 | Peter McGregor | 100,000 | $0.484 | $48,368.00 |
| 16/03/2023 | Mark Tibbles | 505,000 | $0.340 | $171,700.00 |
| 10/03/2023 | Mark Tibbles | 574,451 | $0.340 | $195,313.00 |
| 02/03/2023 | Steve Wedan | 97,540 | $0.320 | $31,213.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Steve Wedan | Chairman, CEO | 25/05/2006 |
| Gregg Stenzel | COO | 30/12/2020 |
| Jonathon Gut | CFO | 01/07/2022 |
| Mark Tibbles | Non Exec Director | 05/09/2014 |
| Peter McGregor | Non Exec Director | 19/05/2019 |
| Anita Messal | Non Exec Director | 01/03/2021 |
| Kobe Li | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
